Dusa Pharmaceuticals Reports Q4 EPS of $0.12

Dusa Pharmaceuticals DUSA reported its Q4 EPS at $0.12, versus the consensus of $0.04. DUSA reported its Q4 revenue at $12 million, versus the consensus of $10.28 million.

DUSA shares gained 7.02% to close at $3.20 yesterday.

Read more <a href="http://www.benzinga.com/markets/company-news">from Benzinga's Company news.</a>